Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLO Allogene Therapeutics Inc.

已收盘 05-20 16:00:00 EDT

2.59

-0.18

-6.50%

盘后2.64

+0.05+1.87%

19:49 EDT

最高2.79	最低2.57	成交量321.04万
今开2.77	昨收2.77	日振幅7.94%
总市值5.41亿	流通市值4.04亿	总股本2.09亿
成交额849.65万	换手率2.06%	流通股本1.56亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":2.59,"timestamp":1716235200000,"preClose":2.77,"halted":0,"volume":3210411,"hourTrading":{"tag":"盘后","latestPrice":2.6384,"preClose":2.59,"latestTime":"19:49 EDT","volume":39306,"amount":102344.1355,"timestamp":1716248988967},"delay":0,"floatShares":156000000,"shares":208784414,"eps":-1.792431,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.18,"latestTime":"05-20 16:00:00 EDT","open":2.77,"high":2.79,"low":2.57,"amount":8496510.021638999,"amplitude":0.079422,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.792431,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716278400000},"adr":0,"listingDate":1539230400000,"adjPreClose":2.77,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.81,"preClose":2.77,"latestTime":"09:26 EDT","volume":31852,"amount":89412.41809199999,"timestamp":1716211618947},"postHourTrading":{"tag":"盘后","latestPrice":2.6384,"preClose":2.59,"latestTime":"19:49 EDT","volume":39306,"amount":102344.1355,"timestamp":1716248988967},"volumeRatio":0.866164},"requestUrl":"/m/hq/s/ALLO","defaultTab":"news","newsList":[{"id":"2436538181","title":"Allogene Therapeutics, Inc.2024财年第一财季实现净利润-65.00百万美元，同比增加34.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436538181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436538181?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:25","pubTimestamp":1716049528,"startTime":"0","endTime":"0","summary":"3月31日，Allogene Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-65.00百万美元，同比增加34.14%；其中营业收入为22000.00美元，同比减少57.69%，每股基本收益为-0.38美元。从资产负债表来看，Allogene Therapeutics, Inc.总负债1.25亿美元，其中短期债务6.93百万美元，资产负债比为4.69，流动比率为0.13。机构评级：截至2024年3月31日，当前有12家机构对Allogene Therapeutics, Inc.目标价做出预测，其中目标均价为11.59美元，其中最低目标价为4.50美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253287781109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253287781109&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435375753","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435375753","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435375753?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:04","pubTimestamp":1715609052,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时04分，Allogene Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220412861ecd3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220412861ecd3d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434779662","title":"Allogene Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434779662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434779662?lang=zh_cn&edition=full","pubTime":"2024-05-09 00:52","pubTimestamp":1715187127,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日00时52分，Allogene Therapeutics, Inc.股票出现异动，股价快速跳水5.15%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900520787e867df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900520787e867df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432970684","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970684","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432970684?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743124,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Allogene Therapeutics, Inc.股票出现波动，股价大幅上涨5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213204861ead36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213204861ead36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431086989","title":"Allogene Therapeutics, Inc.盘中异动 快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431086989","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431086989?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397484,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Allogene Therapeutics, Inc.股票出现异动，股价大幅拉升5.10%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131247924ebb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131247924ebb4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431783725","title":"Allogene Therapeutics Inc    预计每股亏损 41 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431783725","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431783725?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:28","pubTimestamp":1714390139,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc    预计将在5月1日公布截至2024年3月31日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从一年前的5.2万美元下降81.5%至960万美元。* LSEG 分析师对 Allogene Therapeutics Inc 的平均预期是每股亏损 41 美分。* 华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 2.89 美元。4月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427889460","title":"Allogene Therapeutics, Inc.盘中异动 快速下挫5.00%报3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427889460","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427889460?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:48","pubTimestamp":1713199683,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时48分，Allogene Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600480487e8081c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600480487e8081c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426912094","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426912094","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426912094?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755846,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Allogene Therapeutics, Inc.股票出现异动，股价急速跳水5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102130477a51e7a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102130477a51e7a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422591254","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.11%报4.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422591254","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422591254?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:29","pubTimestamp":1711553396,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日23时29分，Allogene Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327232957791d5053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327232957791d5053&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420724584","title":"Allogene Therapeutics, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420724584","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420724584?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:42","pubTimestamp":1710769340,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时42分，Allogene Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为63.18%、12.33%、9.47%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Immuneering Corporation、Elicio Therapeutics, Inc.，振幅分别为23.07%、23.04%、16.20%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182142217a4d6f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182142217a4d6f9b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419744569","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅拉升5.23%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419744569","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419744569?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:31","pubTimestamp":1710509500,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时31分，Allogene Therapeutics, Inc.股票出现异动，股价大幅拉升5.23%。截至发稿，该股报4.73美元/股，成交量15.0805万股，换手率0.09%，振幅0.33%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Better Therapeutics, Inc.、杰龙、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Kintara Therapeutics, Inc.较为活跃，换手率分别为124.67%、57.89%、10.29%，振幅较大的相关个股有Better Therapeutics, Inc.、联拓生物、Tracon Pharmaceuticals, Inc.，振幅分别为18.00%、14.17%、13.07%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213140791adaa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213140791adaa8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419953263","title":"阿洛金治疗公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2419953263","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419953263?lang=zh_cn&edition=full","pubTime":"2024-03-15 05:01","pubTimestamp":1710450092,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc   报告，截至12月底的季度调整后每股亏损43美分，高于去年同期的每股-66美分。16 位分析师对该季度的平均预期是每股亏损 45 美分。华尔街预期为每股-62美分至-34美分。* 收入同比下降 55.3%，为 2.1 万美元；分析师预期为 2.357 万美元。* Allogene Therapeutics Inc 公布的本季度每股收益为亏损 51 美分。* 该公司当季亏损 8,578 万美元。* 本季度，Allogene Therapeutics Inc 的股价上涨了 52.0%。华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419760218","title":"Allogene Therapeutics, Inc.盘中异动 快速下挫5.53%报4.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419760218","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419760218?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:38","pubTimestamp":1710423514,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时38分，Allogene Therapeutics, Inc.股票出现异动，股价大幅下挫5.53%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Nutriband Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.、First Wave Biopharma, Inc.较为活跃，换手率分别为125.17%、62.01%、52.03%，振幅较大的相关个股有Nuvectis Pharma, Inc.、Nutriband Inc C/Wts 、Coherus Biosciences, Inc.，振幅分别为24.38%、19.20%、16.30%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213834791a7beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213834791a7beb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418067875","title":"Allogene Therapeutics, Inc.盘中异动 大幅跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418067875","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418067875?lang=zh_cn&edition=full","pubTime":"2024-03-09 01:16","pubTimestamp":1709918166,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日01时16分，Allogene Therapeutics, Inc.股票出现波动，股价急速下挫5.21%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。消息层面，截至01时16分，《Allogene TherapeuticsParker Geoffrey M.增持190股普通股股份，价值约683.05美元》资讯为影响Allogene Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030901160687e775f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030901160687e775f4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417912609","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.06%报5.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417912609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417912609?lang=zh_cn&edition=full","pubTime":"2024-03-05 00:18","pubTimestamp":1709569083,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日00时18分，Allogene Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报5.19美元/股，成交量55.1833万股，换手率0.33%，振幅6.88%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305001803861db0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305001803861db0ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414880362","title":"Allogene Therapeutics Inc盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414880362","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414880362?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:32","pubTimestamp":1709044329,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时32分，Allogene Therapeutics Inc股票出现波动，股价快速拉升5.40%。截至发稿，该股报4.88美元/股，成交量4.676万股，换手率0.03%，振幅2.59%。Allogene Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为309.18%、83.77%、29.60%，振幅较大的相关个股有Viking Therapeutics Inc、Fate Therapeutics、Janux Therapeutics Inc，振幅分别为21.70%、17.84%、14.57%。Allogene Therapeutics Inc公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722321079151993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722321079151993&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":0.0036},{"period":"1month","weight":-0.2108},{"period":"3month","weight":-0.4217},{"period":"6month","weight":-0.061},{"period":"1year","weight":-0.5444},{"period":"ytd","weight":-0.1371}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司，开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列，旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的，这意味着它们来自健康供体，用于任何患者，而不是来自患者的个体患者，如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071404},{"month":2,"riseRate":0.666667,"avgChangeRate":0.050796},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.111126},{"month":4,"riseRate":0.5,"avgChangeRate":0.005289},{"month":5,"riseRate":0.333333,"avgChangeRate":0.04893},{"month":6,"riseRate":0.6,"avgChangeRate":0.062358},{"month":7,"riseRate":0.4,"avgChangeRate":-0.002168},{"month":8,"riseRate":0.4,"avgChangeRate":-0.044471},{"month":9,"riseRate":0.6,"avgChangeRate":-0.052215},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105941},{"month":11,"riseRate":0.333333,"avgChangeRate":0.009962},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.098907}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}